MIV 710
/ Medivir
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 25, 2017
A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients
(clinicaltrials.gov)
- P2; N=50; Active, not recruiting; Sponsor: Medivir; Recruiting ➔ Active, not recruiting; N=80 ➔ 50
Enrollment change • Enrollment closed • Biosimilar • CNS Disorders • Demo Pain • Immunology • Inflammation • Osteoarthritis • Pain
1 to 1
Of
1
Go to page
1